Left ventricular function in patients with type 2 diabetes mellitus

      This study showed that the mean left ventricular ejection fraction, end-diastolic volume, end-systolic volume, and muscle mass are comparable in patients with type 2 diabetes mellitus to gender-matched patients who do not have diabetes mellitus, but abnormal ejection fraction is more common in men, although not in women, with diabetes mellitus than without. The ejection fraction was higher and the volumes and muscle mass were lower in women than men in the presence or absence of diabetes mellitus.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rubler S.
        • Dlugash J.
        • Yuceoglu Y.Z.
        • Kumral T.
        • Branwood A.W.
        • Grishman A.
        New type of cardiomyopathy associated with diabetic glomerulosclerosis.
        Am J Cardiol. 1972; 30: 595-602
        • Romanens M.
        • Fankhauser S.
        • Saner B.
        • Michaud L.
        • Saner H.
        No evidence for systolic or diastolic left ventricular function at rest in selected patients with long-term type I diabetes mellitus.
        Eur J Heart Fail. 1999; 1: 169-175
        • Cosson S.
        • Kevorkian J.P.
        Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?.
        Diabetes Metab. 2003; 29: 455-466
        • Mustonen J.N.
        • Uusitupa M.I.
        • Laakso M.
        • Vanninen E.
        • Lansimies E.
        • Kuikka J.T.
        • Pyorala K.
        Left ventricular systolic function in middle-aged patients with diabetes mellitus.
        Am J Cardiol. 1994; 73: 1202-1208
        • Manchikalapudi P.
        • Biederman R.
        • Dayle M.
        • Fuisz A.
        • Pohost G.M.
        • Howard G.
        • Paine T.
        • Rogers W.J.
        • Iskandrian A.E.
        Validation of left ventricular mass by SPECT sestamibi imaging.
        J Nucl Cardiol. 2000; 7 (abstr): 185
        • Butler R.A.
        • MacDonald T.M.
        • Struthers A.D.
        • Morris A.D.
        The clinical implications of diabetic heart disease.
        Eur Heart J. 1998; 19: 1617-1627
        • Aronow W.S.
        • Ahn C.
        Incidence of heart failure in 2,737 older persons with and without diabetes mellitus.
        Chest. 1999; 115: 867-868
        • Kannel W.B.
        • Hjortland M.
        • Castelli W.P.
        Role of diabetes in congestive heart failure: Framingham study.
        Am J Cardiol. 1974; 34: 29-34
        • He J.
        • Ogden L.G.
        • Bazzano L.A.
        • Vupputuri S.
        • Loria C.
        • Whelton P.K.
        Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.
        Arch Intern Med. 2001; 161: 996-1002
        • Forsblom C.M.
        • Sane T.
        • Groop P.H.
        • Totterman K.J.
        • Kallio M.
        • Saloranta C.
        • Laasonen L.
        • Summanen P.
        • Lepantalo M.
        • Laatikainen L.
        • et al.
        Risk factors for mortality in type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4.
        Diabetologia. 1998; 41: 1253-1262
        • Kannel W.B.
        • McGee D.L.
        Diabetes and cardiovascular disease: the Framingham study.
        JAMA. 1979; 241: 2035-2038
        • Fein F.S.
        • Sonnenblick E.H.
        Diabetic cardiomyopathy.
        Cardiovasc Drugs Ther. 1994; 8: 65-73
        • Bell D.S.
        Diabetic cardiomyopathy.
        Diabetes Care. 1995; 18: 708-714
        • Neely J.R.
        • Rovetto M.J.
        • Oram J.F.
        Myocardial utilization of carbohydrate and lipid.
        Prog Cardiovasc Dis. 1972; 15: 289-329
        • Chiu H.C.
        • Kovacs A.
        • Ford D.A.
        • Hsu F.F.
        • Garcia R.
        • Herrero P.
        • Saffitz J.E.
        • Schaffer J.E.
        A novel mouse model of lipotoxic cardiomyopathy.
        J Clin Invest. 2001; 107: 813-822
        • Galderisi M.
        • Anderson K.M.
        • Wilson P.F.
        • Levy D.
        Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study).
        Am J Cardiol. 1991; 68: 85-89
        • Raev D.C.
        Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients.
        Diabetes Care. 1994; 17: 633-639
        • Harrower A.D.
        • Railton R.
        • Small D.
        Comparison by nuclear angiography of resting left ventricular function on insulin-dependent diabetic patients and normal subjects and the effect of diabetic control.
        Diabetes Res. 1984; 1: 227-229
        • Fang Z.Y.
        • Najos-Valencia O.
        • Leano R.
        • Marwick T.H.
        Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine.
        J Am Coll Cardiol. 2003; 42: 446-453
        • Struthers A.D.
        • Morris A.D.
        Screening for and treating left ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths.
        Lancet. 2002; 359: 1430-1432